FDA.reportPublic FDA data

heparin sodium, porcine 3,000 UNT / taurolidine 40.5 MG per 3 ML Injection

RxCUI
2670461
RxNorm name
heparin sodium, porcine 3,000 UNT / taurolidine 40.5 MG per 3 ML Injection
Display name
heparin sodium, porcine 3,000 UNT / taurolidine 40.5 MG per 3 ML Injection
Full name
heparin sodium, porcine 3,000 UNT / taurolidine 40.5 MG per 3 ML Injection
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:48

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
DEFENCATHTAUROLIDINE AND HEPARINCorMedix Inc.13b3a61e-5a4b-4afb-8fa1-d76ebdb344d62026-09-04Warnings, Adverse reactionsExact identifier
rxcui: 2670461

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
13b3a61e-5a4b-4afb-8fa1-d76ebdb344d6heparin sodium, porcine 3,000 UNT / taurolidine 40.5 MG in 3 ML Injection [PSN] · 3 ML heparin sodium, porcine 1000 UNT/ML / taurolidine 13.5 MG/ML Injection [SCD] · heparin sodium, porcine 3,000 UNT / taurolidine 40.5 MG per 3 ML Injection [SY]37These highlights do not include all the information needed to use DEFENCATH safely and effectively. See full prescribing information for DEFENCATH. DEFENCATH ® (taurolidine and heparin) catheter lock solution, for central venous catheter instillation use Initial U.S. Approval: 2023 LIMITED POPULATION20250929